<img alt="" src="https://secure.52enterprisingdetails.com/787780.png" style="display:none;">
Skip to content

Catarina Carrão

Regulatory Clinical Evaluation & Assessment
BioSciPons
Austria

Catarina Carrão is the founder of BioSciPons, a life sciences research organization providing regulatory intelligence, clinical development, evaluation and impact monitoring for health technologies, specializing in AI-enabled medical technologies and digital twins. Carrão's academic background includes a Marie-Curie Fellowship at Medical University Charité Berlin, Postdoctoral Fellowships at Medical University of Vienna, and Yale University Cardiovascular Research Center.

Since 2013, she is a Fellow of the American Heart Association (FAHA). She is also a Delegate of RAPS, the European Society of Cardiology (ESC), and member of the Professional Society for Health Economics and Outcomes Research (ISPOR) organization. She is an expert for the European Health and Digital Executive Agency (HaDEA), European Innovation Council (EIC), European Innovation Technology (EIT) Council Health Cluster, and the International Rare Diseases Research Consortium (IRDiRC) on Digital Twins.

Topics

Governance and Post-Market Monitoring of Healthcare AI

International Programme
Developing Health Technology
11.2.2027 11:00 - 11:40 | Branded Lecture Hall 1

AI models used in clinical care don’t stay fixed once deployed. As patient populations, clinical practices, and data sources change, model performance can quietly degrade over time. Through a real-world case study of predictive healthcare AI, this session will introduce post-market monitoring regulatory requirements for AI-enabled Clinical Decision Support Software (AI-CDSS) and the governance needed to support them.